万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
http://journals.lww.com/ear-hearing/Pages/default.aspx
3、投稿网址：http://www.editorialmanager.com/eandh/
4、官网邮箱：emily.hurd@wolterskluwer.com（编辑部）
5、期刊刊期：双月刊，一年出版6期。
2021年5月31日星期一
投稿须知【官网信息】
Instructions for Authors
GENERAL INFORMATION
Scope: Ear and Hearing publishes articles of interest to those involved in the assessment, diagnosis, and management of auditory and vestibular disorders. The Journal places a high priority on innovative, hypothesis-driven experimental studies including those involving clinical patients. Case reports and case series are only considered when they are of overwhelming clinical interest and also contribute substantial new knowledge to the literature base.
The journal is of primary interest to audiologists, otologists, educators, and to those involved in the design, manufacture, and distribution of amplification systems. The goals of the Journal are in harmony with the aims of The American Auditory Society: to increase knowledge of human hearing, to promote conservation of hearing, and to foster (re)habilitation of persons with hearing impairments.
Open access
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. Authors may take advantage of the open access option at the point of acceptance to ensure that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.
The article processing charge (APC) is charged on acceptance of the article and should be paid within 30 days by the author, funding agency or institution. Payment must be processed for the article to be published open access. For a list of journals and pricing please visit our Wolters Kluwer Open Health Journals page.
Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access. Authors grant Wolters Kluwer an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license. Please visit our Open Access Publication Process page for more information.
Creative Commons license
Open access articles are freely available to read, download and share from the time of publication under the terms of the Creative Commons License Attribution-NonCommerical No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission.
Compliance with funder mandated open access policies
An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license is able to meet that requirement through the available open access license for approved funders. Information about the approved funders can be found here: http://www.wkopenhealth.com/inst-fund.php
RCUK funded authors can choose to publish their paper as open access with the payment of an article process charge, or opt for their accepted manuscript to be deposited (green route) into PMC with an embargo.
With both the gold and green open access options, the author will continue to sign the Copyright Transfer Agreement (CTA) as it provides the mechanism for LWW to ensure that the author is fully compliant with the requirements. After signature of the CTA, the author will then sign a License to Publish where they will then own the copyright.
It is the responsibility of the author to inform the Editorial Office and/or LWW that they have RCUK funding. LWW will not be held responsible for retroactive deposits to PMC if the author has not completed the proper forms.
FAQ for open access
http://www.wkopenhealth.com/openaccessfaq.php
Ethical/Legal Considerations: A submitted manuscript must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.
Patient Anonymity and Informed Consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Conflicts of Interest: Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript in a separate section titled “Acknowledgements”. All relevant conflicts of interest and sources of funding should also be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:”. For example:
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors, none were declared.
Copyright: In addition, each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors, "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (www.icmje.org/update.html).
A copy of the form is made available to the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with instructions on completing the form upon submission.
Compliance With NIH and Other Research Funding Agency Accessibility Requirements: A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print version of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central.
Publication Charges: No page charges are imposed for the first 12 printed and published pages. If the paper’s published length exceeds 12 pages, there is a charge of $125 per page (for example, for a 13 printed page article, the charge is $125; for 14 printed pages the charge is $250). No changes in overall content to reduce page number will be allowed after the manuscript is accepted for publication. Information about page charges will be sent with the author’s proof. Page charges will be billed after print publication.
Please note that approximately 10,000 words (including references, figure legends, and table legends) yields 12 printed pages. Four figures will be the equivalent of approximately 1 published page. If your estimate of published pages exceeds 12, please shorten your paper prior to submission in order to avoid page charges.
Authors may choose to publish some material as Supplemental Digital Content online (see SDC reference below). Authors are required to submit all Appendix material as SDC.
Color Figure Charges: There is no charge for color figures appearing in the online version of Ear and Hearing.
Manuscript Type: The following guide should be consulted when selecting from the "Manuscript Type" drop down menu during the submission process. Authors are encouraged also to consult reporting guidelines relevant to their specific research design. A good source of reporting guidelines is the EQUATOR Network (http://www.equator-network.org/home/).
Research Article: This is the typical type of article published in the journal. In general, it should follow the traditional structure including the following sections: Abstract, Introduction, Methods, Results, and Discussion. Any departure from this structure should be discussed with a member of the Editorial Board. See the "Preparation of Manuscript" section for more details about the structured abstract required by Ear & Hearing, as well as other details. The structured abstract should be written in third person and in active voice.
Research Articles including Electrophysiological Tests: Manuscripts that present human electrophysiologic tests as outcome measures should include exemplar waveform data. Such waveforms provide opportunities for reviewers and readers to judge data quality, both in terms of SNR and repeatability. Authors using human electrophysiology are encouraged to review the publication guidelines published by Picton and colleagues (2000). For some electrophysiologic measures waveform data is not informative and a satisfactory justification for not including waveform data should be provided in the manuscript.
(Picton TW, Bentin S, Berg P, Donchin E, Hillyard SA, Johnson R Jr, Miller GA, Ritter W, Ruchkin DS, Rugg MD, Taylor MJ., Guidelines for using human event-related potentials to study cognition: recording standards and publication criteria. Psychophysiology. 2000 Mar;37(2):127-52.)
Research Articles including Objective Vestibular Tests: It is recommended that manuscripts presenting data using non-electrophysiologic objective vestibular testing results (e.g. videohead impulse testing) include raw data. Those tests are strongly operator specific and the raw data will allow the reviewers and the readership the opportunity to review the quality of the information on which the analysis is based.
Randomized Control Trials and Clinical Trials: In order to improve the clarity and uniformity of reporting trials, Ear and Hearing supports the ICMJE policy on trial registration. The ICMJE requires the registration of clinical trials in a public trials registry at or before the time of first patient enrollment. ICMJE defines clinical trial as: "any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome." Examples of interventions may include, but are not limited to, drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, and the like.
As a condition of consideration for publication, Ear and Hearing requires registration in a public trials registry. Trials must register before the onset of patient enrollment. This policy applies to any clinical or randomized control trial. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase 1 trials) are exempt. We do not advocate one particular registry, but registration must be with a registry that meets the following minimum criteria: Accessible to the public at no charge, searchable by standard electronic (Internet-based) methods, open to all prospective registrants free of charge or at minimal cost, validation of registered information, and identification of trials with a unique number. An acceptable registry must collect information on the investigator(s), the research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of original registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing, or closed), and funding source (s). The registration number and the date of original registration should be included within the "Methods" section of your manuscript submission.
Registries that currently meet these criteria include the following:
The registry sponsored by the US National Library of Medicine (www.clinicaltrials.gov)
The International Standard Randomized Controlled Trial Number Registry (www.controlled-trials.com)
The Cochrane Renal Group Registry (www.cochrane-renal.org)
The National (UK) Research Register (www.update-software.com)
European Clinical Trials Database (http://eudract.emea.eu.int/)
Authors preparing reports of randomized clinical trials are encouraged to consult the CONSORT checklist (http://www.consort-statement.org/index.aspx?o=2965) and to include a CONSORT flow diagram (http://www.consort-statement.org/consort-statement/flow-diagram0/) as a figure in the manuscript. A copy of the CONSORT checklist and flow diagram must be submitted with the manuscript.
Authors of observational studies are encouraged to consult the STROBE checklists (http://www.strobe-statement.org/). Purely observational studies, studies in which assignment of medical interventions are not at the discretion of investigators, do not require registration.
Data Sharing: Ear and Hearing supports the ICMJE policy on data sharing for clinical trial submissions Please submit a Data sharing statement with your submission. (see examples on page 14 of http://www.icmje.org/icmje-recommendations.pdf).
Systematic Review, Scoping Review, and Meta-Analysis: Ear and Hearing supports the Reporting Guidelines outlined in the International Committee of Medical Journal Editors (ICMJE) Systematic Reviews and Meta-Analysis (http://www.icmje.org/recommendations/). In order to improve the clarity and uniformity of reporting such studies Ear and Hearing strongly encourages authors of reports of meta-analyses of clinical trials to adhere to the guidelines for reporting Systematic Reviews, Scoping Reviews, and Meta-Analysis promulgated by PRISMA and requires that manuscripts submitted in this category are accompanied by a completed PRISMA flow diagram AND checklist (http://www.prisma-statement.org/; http://www.prisma-statement.org/Extensions/ScopingReviews). Authors of meta-analysis of observational studies should submit the MOOSE checklist. (http://www.equator-network.org/reporting-guidelines/meta-analysis-of-observational-studies-in-epidemiology-a-proposal-for-reporting-meta-analysis-of-observational-studies-in-epidemiology-moose-group/).
Current State of Knowledge: Papers submitted under this category provide not only a comprehensive review of the literature in a particular topic area but also represent some attempt at consensus regarding the state of the science and or clinical practice in the area. These submissions undergo regular peer review, and in the case of multiple submissions in one topic area undergo a second tier review by the Editorial Board in order to ensure that the submissions forma coherent compendium of information for readers.
Editorial: Editorials are generally written by members of the Editorial Board. Unsolicited editorials are not accepted.
Review: Submissions such as tutorials or reviews may provide a general (traditional) abstract rather than the Structured Abstract required for research articles.
Brief Report: A Brief Report includes any communication encompassing technical notes, calibration studies, clinical reports, pilot research, and case reports. Authors are invited to submit clinical or technical material that is consistent with the purposes of the Journal. Ear and Hearing normally does not publish case studies unless they are of overwhelming clinical interest, include enough case examples to draw a conclusion that is empirically and hypothesis-based, and describe novel findings not previously reported in the extant literature. Brief Reports will not exceed 1500 words, should have 15 or fewer references, and should have no more than 3 illustrations or tables. The submission should include a structured abstract of 150 words or less (see below under "preparation of manuscript") for more details about the Structured Abstract required by Ear and Hearing. Exceptions may be granted to Reports of a highly technical nature. Brief Reports are peer reviewed on the same basis as articles of standard length.
Point of View: Point of View articles typically have a slant or opinion. This type of article should have a fresh point of view, a clear logic to its propositions, and a clarity of presentation. The article must have a well-reasoned point of view, but the view does not have to be balanced. Our long-term goal for the Point of View article is to stimulate the field's interest in and to enhance the appreciation of the author's area of expertise.
Perspective: Perspective articles typically present a new and unique approach to current problems, fundamental concepts, or prevalent notions relating to hearing and balance. They may propose or suggest new hypotheses, or discuss the implications of current innovations or applications to the study of hearing and balance diagnosis or treatment. Perspective articles may focus on current advances and future directions on a topic, and may include original data. These are usually short peer-reviewed articles of less than 5,000 words. A perspective article usually includes a short abstract of around 150 words and a few tables and figures, if required.
Letter to the Editor: Letters discussing aspects of papers published in the journal are acceptable, but they are subject to review by the Editorial Board and/or external reviewers. In general, they will be published together with a response from the authors of the original article.
……
更多详情：
http://edmgr.ovid.com/eandh/accounts/ifauth.htm
